Single‐cell RNA sequencing reveals the heterogeneity of MYH11 + tumour‐associated fibroblasts between left‐sided and right‐sided colorectal cancer
Journal of Cellular and Molecular Medicine · 2024-09 · 28 (18)
DOI: 10.1111/jcmm.70102 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 18.09.2024. Verfasst von Chao Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, Heilongjiang, China. Hauptthemen laut MEDLINE: Cancer-Associated Fibroblasts, Colorectal Neoplasms, Myosin Heavy Chains, Single-Cell Analysis. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Tou-Yan Innovation Team Program of the Heilongjiang Province, National Natural Science Foundation of China.
Abstract (Originalsprache)
Colorectal cancer (CRC) exhibits considerable heterogeneity on tumour location. However, there is still a lack of comprehensive annotation regarding the characteristics and differences between the left‐sided (L‐CRC) and right‐sided (R‐CRC) CRC. Here, we performed single‐cell RNA sequencing (scRNA‐seq) on immune and stromal cells from 12 L‐CRC and 10 R‐CRC patients. We found that L‐CRC exhibited stronger tumour invasion and poor prognosis compared with R‐CRC. In addition, functional enrichment analysis of a normal cohort showed that fibroblasts of left colon are associated with tumour‐related pathways. This suggested that the heterogeneity observed in both L‐CRC and R‐CRC may be influenced by the specific location within the colon itself. Further, we identified a potentially novel MYH11+ cancer‐associated fibroblast (CAF) subset predominantly enriched in L‐CRC. Moreover, we found that MYH11+ CAFs may promote tumour migration via interacting with macrophages, and was associated with poor prognosis in CRC. In summary, our study revealed the crucial role of MYH11+ CAFs in predicting a poor prognosis, thereby contributing valuable insights to the exploration of heterogeneity in L‐CRC and R‐CRC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, Heilongjiang, China.
- The 2nd Affiliated Hospital of Harbin Medical University, Harbin Medical University, Harbin, Heilongjiang, China.
- NHC Key Laboratory of Molecular Probe and Targeted Diagnosis and Therapy, Harbin Medical University, Harbin, Heilongjiang, China.
ORCID-Profile: Liang Cheng
Förderung
- Tou-Yan Innovation Team Program of the Heilongjiang Province
- National Natural Science Foundation of China
Zitieren
APA
Wang, C., Zhao, Y., Zhang, S., Du, M., He, G., Tan, S., Li, H., Zhang, D., & Cheng, L. (2024). Single‐cell RNA sequencing reveals the heterogeneity of MYH11 + tumour‐associated fibroblasts between left‐sided and right‐sided colorectal cancer. Journal of Cellular and Molecular Medicine, 28(18). https://doi.org/10.1111/jcmm.70102
Vancouver
Wang C, Zhao Y, Zhang S, Du M, He G, Tan S, et al. Single‐cell RNA sequencing reveals the heterogeneity of MYH11 + tumour‐associated fibroblasts between left‐sided and right‐sided colorectal cancer. Journal of Cellular and Molecular Medicine. 2024;28(18). doi:10.1111/jcmm.70102
BibTeX
@article{Wang2024,
author = {Wang, Chao and Zhao, Yue and Zhang, Sainan and Du, Meiyu and He, Guanzhi and Tan, Senwei and Li, Hailong and Zhang, Duoyi and Cheng, Liang},
title = {Single‐cell RNA sequencing reveals the heterogeneity of MYH11 + tumour‐associated fibroblasts between left‐sided and right‐sided colorectal cancer},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
volume = {28},
number = {18},
doi = {10.1111/jcmm.70102}
}
EUVIMED